The estimated Net Worth of Jacqueline B Kosecoff is at least $1.42 Million dollars as of 13 May 2024. Jacqueline Kosecoff owns over 4,584 units of Steris Plc stock worth over $1,109,603 and over the last 19 years he sold STE stock worth over $0. In addition, he makes $309,919 as Independent Director at Steris Plc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Jacqueline Kosecoff STE stock SEC Form 4 insiders trading
Jacqueline has made over 12 trades of the Steris Plc stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 4,584 units of STE stock worth $236,214 on 13 May 2024.
The largest trade he's ever made was exercising 4,657 units of Steris Plc stock on 15 May 2023 worth over $204,535. On average, Jacqueline trades about 520 units every 96 days since 2005. As of 13 May 2024 he still owns at least 4,584 units of Steris Plc stock.
You can see the complete history of Jacqueline Kosecoff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jacqueline Kosecoff biography
Dr. Jacqueline B. Kosecoff Ph.D. serves as Independent Director of the Company. She director since October 2003 and, since March 2012, Managing Partner, Moriah Partners, LLC, a private equity firm focused on health services and technology, and Senior Advisor to Warburg Pincus LLC, a private equity fund. She also has served as a member of the Executive Advisory Board of SAP America, Inc., a software and enterprise applications provider, from November 2010 through May 2017. From October 2007 to November 2011, Dr. Kosecoff served as Chief Executive Officer of OptumRx (formerly named Prescriptions Solutions), a pharmacy benefits management company and subsidiary of UnitedHealth Group, and continued to serve as a senior advisor to OptumRx from December 2011 to February 2012. Dr. Kosecoff served as Chief Executive Officer of Ovations Pharmacy Solutions, a UnitedHealth Group company, from December 2005 to October 2007. From July 2002 to December 2005, Dr. Kosecoff served as Executive Vice President, Specialty Companies, of PacifiCare Health Systems, Inc., one of the nation’s largest consumer health organizations. From 1998 to 2002, Dr. Kosecoff was President and Founder of Protocare, Inc., a firm involved in the development and testing of drugs, devices, biopharmaceutical and nutritional products, and consulting and analytic services. Dr. Kosecoff is a director of Sealed Air Corporation,, Houlihan Lokey and Trinet Group, Inc. Dr. Kosecoff served as a director of athenahealth, Inc. until February 2019.
What is the salary of Jacqueline Kosecoff?
As the Independent Director of Steris Plc, the total compensation of Jacqueline Kosecoff at Steris Plc is $309,919. There are 12 executives at Steris Plc getting paid more, with Walter Rosebrough having the highest compensation of $6,458,640.
How old is Jacqueline Kosecoff?
Jacqueline Kosecoff is 71, he's been the Independent Director of Steris Plc since 2003. There are 1 older and 21 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
What's Jacqueline Kosecoff's mailing address?
Jacqueline's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Insiders trading at Steris Plc
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough, and John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
What does Steris Plc do?
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
What does Steris Plc's logo look like?
Complete history of Jacqueline Kosecoff stock trades at Houlihan Lokey Inc, Sealed Air, Steris Plc, TriNet Inc, and GoodRx
Steris Plc executives and stock owners
Steris Plc executives and other stock owners filed with the SEC include:
-
Walter Rosebrough,
President, Chief Executive Officer, Director -
Walter M. Rosebrough Jr.,
CEO Emeritus & Sr. Advisor -
Michael Tokich,
Chief Financial Officer, Senior Vice President -
Daniel Carestio,
Chief Operating Officer, Senior Vice President -
J. Adam Zangerle,
Senior Vice President, General Counsel, Secretary -
Daniel A. Carestio,
Pres, CEO & Director -
Cary Majors,
Vice President - North America Commercial Operations -
Michael J. Tokich,
Sr. VP & CFO -
John Adam Zangerle,
Sr. VP, Gen. Counsel, Sec. -
Cary L. Majors,
Sr. VP of North America Commercial Operations -
Mohsen Sohi,
Independent Chairman of the Board -
David Lewis,
Independent Director -
Jacqueline Kosecoff,
Independent Director -
Richard Steeves,
Independent Director -
Richard Breeden,
Independent Director -
Loyal Wilson,
Independent Director -
Nirav Shah,
Independent Director -
Cynthia Feldmann,
Independent Director -
Duncan Nichol,
Independent Director -
Michael Wood,
Independent Director -
Christopher Holland,
Director -
Renato Tamaro,
Vice President and Corporate Treasurer -
Renato G. Tamaro,
VP & Corp. Treasurer -
Julia K. Madsen,
Sr. VP of Life Sciences -
Mary Clare Fraser,
VP & Chief HR Officer -
Julie Winter,
VP of Investor Relations & Corp. Communications -
Karen L. Burton,
Chief Accounting Officer, VP & Controller -
Esther M. Alegria,
Director -
Kathleen Bardwell,
Sr.V. P. & C.C.O. -
Sudhir K Pahwa,
Sr. V.P., IPT -
Suzanne V Forsythe,
V. P. - Human Resources -
Gulam Amjad Khan,
Sr. V.P., Procedural Solutions -
Adrian Vincent Coward,
Sr. V. P., Healthcare Services -
John P Wareham,
Director -
Michiel De Zwaan,
V.P., Human Resources & CHRO -
Kevin M Mcmullen,
Director -
Mary Clare Fraser,
SVP & Chief HRO -
Julia Madsen,
Senior VP, Life Sciences -
Paul Edward Martin,
Director -
Andrew Xilas,
SVP and GM, Dental -
Kenneth E Kohler,
SVP & GM, AST -
Karen L Burton,
VP & CAO